CoNextions® Inc. Announces Daniel Gruppo as President and Chief Executive Officer

3 years ago

Salt Lake City, Utah, June 27, 2022 (GLOBE NEWSWIRE) -- CoNextions® Inc. Announces Daniel Gruppo as President and Chief Executive…

GUIDEMARK HEALTH AND CYAN HEALTH ARE NOW LUMANITY

3 years ago

GUIDEMARK HEALTH AND CYAN HEALTH ARE NOW LUMANITYName changes come on the heels of being acquired by Lumanity in 2021…

Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%

3 years ago

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)…

Privia Receives HFMA’s MAP Award for High Performance in Revenue Cycle for Seventh Straight Year

3 years ago

ARLINGTON, Va., June 27, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated…

Acer Therapeutics Announces Initiation of its Pivotal Phase 3 DiSCOVER Trial of EDSIVO™ (celiprolol) for the Treatment of Vascular Ehlers-Danlos Syndrome

3 years ago

NEWTON, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a clinical stage pharmaceutical company focused on…

P3 Health Partners Announces Inclusion in the Russell 3000® Index

3 years ago

HENDERSON, Nev., June 27, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered…

Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain

3 years ago

Presentation delivered by Professor Saoirse O’Sullivan at the 32nd Annual ICRS Symposium in Galway, Ireland on Sunday, June 26thSOLANA BEACH, Calif.,…

WIMI Hologram Academy: The Application of Virtual Reality Technology in Vehicle Driving Training System

3 years ago

HONG KONG, June 27, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial

3 years ago

- No Dose-Limiting Toxicities Observed in Lymphoma and Acute Myeloid Leukemia Patients at All Dose Levels Studied To-Date - - Early Indications…

Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments

3 years ago

Investigating the synergy between HSB-1216, a Ferroptosis inducer, and Immune Checkpoint InhibitorsBRIDGEWATER, N.J., June 27, 2022 (GLOBE NEWSWIRE) -- Hillstream…